Comparative evaluation of three mammalian cell transformation assay systems.

R W Tennant, S Stasiewicz, J W Spalding
{"title":"Comparative evaluation of three mammalian cell transformation assay systems.","authors":"R W Tennant,&nbsp;S Stasiewicz,&nbsp;J W Spalding","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>One cellular transformation assay system (Syrian hamster embryo (SHE) primary cells) and two viral mediated transformation systems (primary Syrian hamster embryo cells infected with Simian adenovirus type 7 (SHE/SA7), and a rat fibroblast cell line (2FR450) infected with Rauscher leukemia virus (Rat/RLV] were evaluated using a group of nine \"model\" and five coded chemicals. The purpose of the project was to establish the intra- and interlaboratory reproducibility of the assays and to provide a basis for objective comparisons between the systems. This is a preliminary evaluation of the assay systems using the results for these chemicals tested in eight collaborating laboratories under the auspices of the National Toxicology Program (NTP). The endpoint measured in each system is very different and a positive response in each had to be separately defined. The assay systems all produced a response to carcinogens and in most instances the responses could be qualitatively reproduced in the different laboratories. However, the assays differed significantly in their ability to demonstrate dose-related effects. In addition, multiple tests or modified assay procedures were required with every system in order to insure that chemicals had been adequately tested. In each system, technical or procedural limitations exist that preclude the application of these assays to routine chemical testing at this time. Among these limitations were ambiguity in scoring morphological transformation, significant but poorly defined influence of reagents such as serum or metabolic activation systems on test performance, and difficulty in repeating responses to a given chemical. Additional efforts to overcome these limitations will be necessary in order to make these test systems of use in routine testing of unknown chemicals for genetic toxicity.</p>","PeriodicalId":77688,"journal":{"name":"Carcinogenesis; a comprehensive survey","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1985-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Carcinogenesis; a comprehensive survey","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

One cellular transformation assay system (Syrian hamster embryo (SHE) primary cells) and two viral mediated transformation systems (primary Syrian hamster embryo cells infected with Simian adenovirus type 7 (SHE/SA7), and a rat fibroblast cell line (2FR450) infected with Rauscher leukemia virus (Rat/RLV] were evaluated using a group of nine "model" and five coded chemicals. The purpose of the project was to establish the intra- and interlaboratory reproducibility of the assays and to provide a basis for objective comparisons between the systems. This is a preliminary evaluation of the assay systems using the results for these chemicals tested in eight collaborating laboratories under the auspices of the National Toxicology Program (NTP). The endpoint measured in each system is very different and a positive response in each had to be separately defined. The assay systems all produced a response to carcinogens and in most instances the responses could be qualitatively reproduced in the different laboratories. However, the assays differed significantly in their ability to demonstrate dose-related effects. In addition, multiple tests or modified assay procedures were required with every system in order to insure that chemicals had been adequately tested. In each system, technical or procedural limitations exist that preclude the application of these assays to routine chemical testing at this time. Among these limitations were ambiguity in scoring morphological transformation, significant but poorly defined influence of reagents such as serum or metabolic activation systems on test performance, and difficulty in repeating responses to a given chemical. Additional efforts to overcome these limitations will be necessary in order to make these test systems of use in routine testing of unknown chemicals for genetic toxicity.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
三种哺乳动物细胞转化试验系统的比较评价。
使用9种“模型”和5种编码化学物质对一种细胞转化试验系统(叙利亚仓鼠胚胎(SHE)原代细胞)和两种病毒介导的转化系统(感染7型猴腺病毒(SHE/SA7)的叙利亚仓鼠胚胎原代细胞,以及感染Rauscher白血病病毒(rat /RLV)的大鼠成纤维细胞系(2FR450)进行了评估。该项目的目的是建立化验在实验室内和实验室间的可重复性,并为系统之间的客观比较提供基础。这是对在国家毒理学规划主持下的8个合作实验室使用这些化学品检测结果的分析系统进行的初步评估。在每个系统中测量的终点是非常不同的,每个系统中的积极反应必须单独定义。这些检测系统都对致癌物产生反应,在大多数情况下,这些反应可以在不同的实验室中定性地再现。然而,两种检测方法在证明剂量相关效应的能力上存在显著差异。此外,每个系统都需要进行多次测试或修改分析程序,以确保化学品得到充分测试。在每个系统中,存在技术或程序上的限制,目前无法将这些分析方法应用于常规化学检测。这些限制包括形态转化评分不明确,血清或代谢激活系统等试剂对测试性能的影响显著但定义不清,以及难以重复对给定化学物质的反应。为了使这些测试系统用于对未知化学品进行遗传毒性的常规测试,需要作出额外的努力来克服这些限制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The premalignant nature of mouse skin papillomas: histopathologic, cytogenetic, and biochemical evidence. Keratin expression in mouse epidermal tumors. Genetic background and development of skin tumors. Development of murine skin neoplasia studied with enzymes used as cell markers. The action of oncogenes and growth factors in tumour initiation and promotion.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1